BRIDGEWATER, N.J. — Amneal Pharmaceuticals, Inc. has appointed David Buchen to the newly expanded role of senior vice president, chief legal officer and corporate secretary, reporting to oresident and chief executive officer Robert Stewart. Buchen will be responsible for leading Amneal’s global legal, Intellectual Property (IP) and corporate compliance functions, as well as aligning the company’s corporate legal strategies to drive Amneal’s continued growth.

Buchen brings more than 25 years of experience in the pharmaceutical industry, with notable expertise driving corporate value creation through world-class legal strategies supporting corporate securities, IP, anti-trust, employment, litigation and Mergers & Acquisitions (M&A).

“David is an exceptional legal talent and we are thrilled to have him on board to lead Amneal’s global legal team,” said president and CEO Robert Stewart. “David’s extensive experience will be especially valuable as we continue to execute on our strategy to drive growth through a combination of internal development, innovative transactions and strategic M&A.”

Most recently, he served as a consultant to the pharmaceutical industry, providing counsel to various global and U.S. manufacturing, marketing and distribution companies.